Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study

Melanoma and Skin Cancer

Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study

Melanoma Res

González-Barrallo I, Castellón Rubio VE, Medina J, España Fernández S, Mujika K, Majem M, Aguado C, Cabrera Suárez MÁ, Palacio I, Osterloh L, Martínez-Fernández A, García-Castaño A

doi: 10.1097/CMR.0000000000001020

Melanoma and Skin Cancer

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Ann Dermatol Venereol

Amici M, Neveu E, Poizeau F, Edeline J, Lesimple T, Oger E, Danton G, Dupuy A, Fouchard M

doi: 10.1016/j.annder.2025.103371

Melanoma and Skin Cancer

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort

Melanoma Res

Macaire C, Lefevre W, Dalac S, Montaudié H, Legoupil D, Dereure O, Dutriaux C, Leccia MT, Aubin F, Grob JJ, Saiag P, De Quatrebarbes J, Maubec E, Lesimple T, Granel-Brocard F, Mortier L, Dalle S, Lebbé C, Prod'homme C

doi: 10.1097/CMR.0000000000000973

Systemic Lupus Erythematosus

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Arthritis Res Ther

Su Z, Zhang C, Gao C, Li C, Li R, Zheng Z

doi: 10.1186/s13075-024-03389-4

Further Publications Rheumatology

Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study

Rheumatology (Oxford)

Gialouri CG, Chalkia A, Koutsianas C, Chavatza K, Argyriou E, Panagiotopoulos A, Karamanakos A, Dimouli A, Tsalapaki C, Thomas K, Orfanos P, Lagiou P, Katsikas G, Boki K, Boumpas D, Petras D, Vassilopoulos D

doi: 10.1093/rheumatology/keae409

Atopic Dermatitis

Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study

Acta Derm Venereol

Calabrese L, Cinotti E, D'Onghia M, Cartocci A, Rubegni P, Maccari F, Boulard C, Reguiai Z, Becherel PA, Jacobzone C, Begon E, Fite C, Walls B, Liegeon AL, Parier J, Chaby G, Perrot JL, Omcci Group

doi: 10.2340/actadv.v105.42275

Further Publications Immunology

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Lancet

Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE, VIVID Study Group

doi: 10.1016/S0140-6736(24)01762-8

Melanoma and Skin Cancer

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

J Eur Acad Dermatol Venereol

Bellinato F, Adami G, Reatini MA, Cattani G, Cannizzaro MV, Del Regno L, Peris K, Gisondi P, Girolomoni G

doi: 10.1111/jdv.20539

Further Publications Immunology

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study

J Eur Acad Dermatol Venereol

Nikolaou V, Panou E, Tsimpidakis A, Koumprentziotis IA, Patsatsi A, Siakantaris M, Kruger-Krasagakis SE, Marinos L, Georgiou E, Lampadaki K, Velissari A, Daponte AI, Doxastaki A, Kaliampou S, Vaiopoulos A, Konstandinou I, Koumourtzis M, Lakiotaki E, Pappa V, Tsamaldoupis A, Stratigos A, Papadavid E

doi: 10.1111/jdv.20350

Related content

Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study

Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study